Regencell Bioscience Holdings Limited Investing Cash Flow
Regencell Bioscience Holdings Limited (RGC) reported Investing Cash Flow of $2.69 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-10-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2025-10-31
| Period end | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|
| 2025-06-30 | $2.69M 20-F · filed 2025-10-31 |
| 2024-06-30 | $5.24M 20-F · filed 2025-10-31 |
| 2023-06-30 | $58.98K 20-F · filed 2025-10-31 |
| 2022-06-30 | -$10.78M 20-F · filed 2024-10-25 |
| 2020-06-30 | -$117.84K 20-F · filed 2022-10-31 |